Skip to main content

Table 1 Clinicopathological characteristics and survival analysis of 51 patients with pulmonary sarcomatoid carcinoma (PSC)

From: Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases

Characters

Case numbers

The median survival time(month)

5-year survival rate (%)

x2

P

Gender

     

  Male

43

6

21.7%

1.424

0.233

  Female

8

4

21.4%

Age

     

  ≤60y

28

8.5

22.4%

4.055

0.044

  >60y

23

4

15.1%

Tumor size

     

  ≤7 cm

25

29

30.8%

21.789

0.000

  >7 cm

26

4

7.7%

Smoking history

     

  No

18

5

25%

0.622

0.430

  Yes

33

6

21.2%

T stage

     

  T1-2

20

32

28.4%

12.423

0.000

  T3-4

31

4

14.2%

Lymph node metastasis

     

  No

27

7

24.2%

2.813

0.093

  Yes

24

4

14.3%

M metastasis

     

  No

38

9

26.1%

36.313

0.000

  Yes

13

3

0

Surgery or not

     

  Yes

37

7

24.1%

7.800

0.005

  No

14

3.5

0

Postoperative chemotherapy

     

  Yes

19

17

38.4%

4.755

0.029

  No

18

5.5

8.5%